In contrast to the silent expression of healthy donor peripheral Tregs, Neuropilin-1 is expressed by approximately 90% of tumor infiltrating Tregs in cancer patients (62) and increased percentage of human Neuropilin-1+ intratumoral Tregs correlates with poor prognosis. This evidence concerns the gene NRP1 and cancer.